We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Xijing Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00844584
First Posted: February 16, 2009
Last Update Posted: February 16, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Xijing Hospital
  Purpose

Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years.

Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room.

Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.


Condition Intervention
Atrial Fibrillation Procedure: epicardial radiofrequency ablation

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

Resource links provided by NLM:


Further study details as provided by Xijing Hospital:

Primary Outcome Measures:
  • Electrocardiography [ Time Frame: 2 years ]

Estimated Enrollment: 20
Study Start Date: October 2008
Estimated Study Completion Date: June 2011
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
ablation
patients with atrial fibrillation underwent radiofrequency ablation with totally thoracoscope.
Procedure: epicardial radiofrequency ablation
epicardial radiofrequency ablation to treat atrial fibrillation under totally thoracoscope
Other Name: radiofrequency ablation

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Any patients with atrial fibrillation

Exclusion Criteria:

  • Patients with hemostasis defects
  • patients can not endure general anesthesia
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00844584


Contacts
Contact: Zhenxiao Jin, MD 86-29-84771022 jinzx10262@yahoo.com.cn
Contact: Dinghua Yi, MD 86-29-84775307 yidinghua@yahoo.com.cn

Locations
China, Shannxi
Institute of Cardiovascular Surgery, Xijing Hospital Recruiting
Xi'an, Shannxi, China, 710032
Contact: Dinghua Yi, MD    86-29-84775307    yidinghua@yahoo.com.cn   
Principal Investigator: Zhenxiao Jin, MD         
Sub-Investigator: Xuezeng Xu, MD         
Principal Investigator: Shiqiang Yu, MD         
Sponsors and Collaborators
Xijing Hospital
Investigators
Study Director: Dinghua Yi, MD Xijing Hospital
  More Information

Responsible Party: Jin Zhenxiao, Xijing Hospital
ClinicalTrials.gov Identifier: NCT00844584     History of Changes
Other Study ID Numbers: xinzangwaike0001
First Submitted: January 14, 2009
First Posted: February 16, 2009
Last Update Posted: February 16, 2009
Last Verified: January 2009

Keywords provided by Xijing Hospital:
Atrial fibrillation
radiofrequency
totally thoracoscope
epicardial

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes